Preventing tuberculosis-related death in children with HIV

Affiliations

¹ Division of Medical Microbiology, Department of Pathology, University of Cape Town, 7925 Cape Town, South Africa; National Health Laboratory Service, Cape Town, South Africa.
² Division of Medical Microbiology, Department of Pathology, University of Cape Town, 7925 Cape Town, South Africa; National Health Laboratory Service, Cape Town, South Africa; Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa. Electronic address: mark.nicol@uct.ac.za.

Comment

Hafsah Deepa Tootla et al. Lancet HIV. 2018 Feb.

. 2018 Feb;5(2):e62-e64.

doi: 10.1016/S2352-3018(17)30208-4. Epub 2017 Nov 23.

¹ Division of Medical Microbiology, Department of Pathology, University of Cape Town, 7925 Cape Town, South Africa; National Health Laboratory Service, Cape Town, South Africa.
² Division of Medical Microbiology, Department of Pathology, University of Cape Town, 7925 Cape Town, South Africa; National Health Laboratory Service, Cape Town, South Africa; Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa. Electronic address: mark.nicol@uct.ac.za.

No abstract available

Comment on

Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study.
Marcy O, Tejiokem M, Msellati P, Truong Huu K, Do Chau V, Tran Ngoc D, Nacro B, Ateba-Ndongo F, Tetang-Ndiang S, Ung V, Dim B, Neou L, Berteloot L, Borand L, Delacourt C, Blanche S; ANRS 12229 PAANTHER 01 Study Group. Marcy O, et al. Lancet HIV. 2018 Feb;5(2):e87-e95. doi: 10.1016/S2352-3018(17)30206-0. Epub 2017 Nov 23. Lancet HIV. 2018. PMID: 29174612